Xing Yan

Title: Innovations of Xing Yan in Pharmaceutical Development

Introduction

Xing Yan is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for fibroblast growth factor receptors. His work is characterized by a focus on innovative chemical compounds that have therapeutic potential.

Latest Patents

Xing Yan holds a patent for "Substituted pyrazoles as inhibitors of fibroblast growth factor receptor." This patent details an indole derivative expressed by Formula (I), along with its preparation method, pharmaceutical salt, and therapeutic uses, especially as an FGFR inhibitor. Each substituent in Formula (I) is defined as specified in the patent specification. This innovation represents a significant advancement in the search for effective treatments targeting fibroblast growth factor receptors.

Career Highlights

Xing Yan is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to the advancement of pharmaceutical sciences. His expertise in the field has positioned him as a valuable asset to his team and the industry.

Collaborations

Xing Yan collaborates with several talented individuals, including Lei Chen and Dongliang Guan. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Xing Yan's contributions to pharmaceutical development, particularly through his patent on FGFR inhibitors, highlight his role as an influential inventor in the industry. His work continues to pave the way for new therapeutic agents that may improve patient outcomes.